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ABSTRACT 
Introduction: Bacterial vaginosis [BV] is a syndrome characterized by a shift in vaginal flora. It is a strong 
independent risk factor for adverse pregnancy outcomes, found in 9% to 23% of pregnant women. Not 
many studies on BV have been conducted among the pregnant women attending Pumwani Maternity 
Hospital in Kenya. This study defined the prevalence and factors for prevalence of BV in pregnant women 
attending Pumwani Maternity Hospital in Nairobi, Kenya. 
Methods: One hundred and fifty women who attended the Pumwani Maternity Hospital Ante natal clinic 
formed the basis of the study. This study received ethical approval from the Pumwani Maternity Hospital 
ante natal department and KEMRI ethics committee. Vaginal swabs were obtained from all the 150 women 
who consented and detailed demographic, sexual and genital hygiene interviews were collected. BV was 
tested using both the Amsel and Nugent’s criteria.  
Results: Of 150 participants, the mean age was 26.02 years, [range 22 [16 – 38] years], 72.7% were aged 21-
30 years. Sixty eight percent were unemployed, 72.6% married, 20.7% reported previous STI including 
HIV, 74%, the age of sexual debut was less than 16 years; 78% had a regular sexual partner, 87.3% of 
them were circumcised male partners, 24% reported douching and 47.3% reported genital washing after 
sex. Twenty point seven percent had BV by Nugent’s criteria. Bacterial vaginosis was associated with 
having given birth only once [20.3% vs. 19.1%; p=0.03], more than one previous birth [19.2% vs. 19.1%; 
p=0.026], previous STI [50% vs. 19.4%; p=0.042] and non-circumcised male partners [18.3% vs. 36.8%; 
p=0.033].  
Conclusion: Bacterial vaginosis is prevalent among pregnant women. The factors associated with BV 
include partners not being circumcised, primiparous and a history of previous STI infections.  
 
                                                      [Afr J Health Sci. 2017; 31(1):13-30] 
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INTRODUCTION 
Bacterial vaginosis [BV] is the disturbed vaginal 
flora, in which normal lactobacilli are replaced by an 
overgrowth of various anaerobic bacteria which 
include Gardnerella vaginalis and Mycoplasma 
hominis among others [1].  It is particularly common 
in the sub-Saharan African region, where prevalence 
rates of upto 50% are common [2].  BV is the most 
common vaginal condition of reproductive age 
women and is the most frequently cited cause of 
vaginal discharge and malodor [1, 3,4]. 
Several studies have documented an increased risk 
for adverse pregnancy outcomes among women with 
conditions like bacterial vaginosis [5]. Data from 
epidemiological surveys show that within countries 
and between countries in the same region ,the 
prevalence and incidence of genital tract infections 
may vary widely even in similar population groups 
[6].Women with BV may be at increased risks of 
sexually transmitted disease, [STD] [7] and HIV. 
The vaginal, is susceptible to infection just like the 
cervix but the etiological agents are distinct because 
of ecological differences between the two sites. In 
women of reproductive age, the pH of the cervix is 
7.0 while that of the healthy vagina is 3.5- 
4.5 [8]. The vagina is lined with squamous epithelial 
cells and the cervix lined with columnar epithelial 
cells. These differences select for specific pathogens, 
primarily Chlamydia trachomatis and Neisseria 
gonorrhoeae in the cervix. A typical clinical 
symptom of BV is a thin, homogenous, gray, 
malodorous vaginal discharge, without significant 
pruritus or pain [9]. However, more than 50% of all 
women with BV are asymptomatic. Diagnosis of BV 
may be established by Amsel’s clinical criteria 
whereby 3 of the 4 following signs are found: 
homogenous discharge, vaginal fluid pH > 4.5, 
positive amine test and microscopic analysis of 
Gram stained smear of vaginal discharge with clue 
cells seen [10]. An alternative diagnostic criterion 
utilizes Gram staining of vaginal secretions [11]. 
This is usually scored using Nugent criteria which is 
the standardized Gram stain method that is more 
accurate hence referred to us Gold standard [12]. The 
Nugent criteria involves standardized evaluation of 
morphtypes on Gram stain analysis for a decrease in 
Lactobacillus morphotypes and increase in 
Gardnerella, Mobiluncus and Bacteroides 
morphotypesand curved gram variable rods [13]. The 
treatment of BV consists of metronidazole or 
clindamycin orally or intravaginally [14]. 
A microbial foundation for BV has been 
demonstrated in which Gardnerella vaginalis, 
anaerobic bacteria and Mycoplasma hominis 
constitute the pathological core of BV [15]. 
Knowledge on the risk factors associated with 
acquisition and elimination of BV is needed for a 
better understanding of the disease and management 
of its outcomes. 
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METHODS 
Study site and population 
This study was carried out at Pumwani Maternity 
Hospital [PMH] antenatal clinic. PMH is the biggest 
maternity hospital in East Africa, having 80 to 100 
deliveries in a day and is located in the Eastern part 
of Nairobi, Kenya. The hospital caters for expectant 
mothers; the majority being from the Eastland area 
of Nairobi and is of middle and low level 
socioeconomic backgrounds.  The target population 
involved pregnant mothers aged between 18-49 
years who were attending the antenatal clinic at 
PMH. 
Study design 
This cross sectional study was carried out among 
pregnant women who attended the antenatal clinic at 
PMH between November and December 2010. 
Sample size estimation 
The sample size of 150 was calculated based on the 
prevalence assumed to be 50% because some women 
are asymptomatic thus not easy to determine the 
exact prevalence. The total sample size was 
calculated using statistical Fischer’s exact 
probability test, and therefore samples were used for 
the study calculated at 95% confidence interval. 
The following formula was used to determine the 
sample size [Olive M, and Abel G, 1999] 
 n= Z2 X pq/ d2  
 
   Z = Standard normal deviation 
at the required confidence interval  
                                                [1.96] 
p = proportion in the target 
population estimated to have 
measured character 
   q = 1 – p  
d = level of statistical 
significance at 95% confidence level 
= 0.05 
        Therefore, sample size calculation is; 
             n =1.962 x [0.5 x [1-0.5]]/0.052 
                 =1.962   x100 
                 =384 samples 
 Because the target population was less than 10,000, 
the final sample estimate was calculated as               
nf =n/1+n]/N [Culhane J, et al 2001] 
Where nf=the desired sample size when population 
is less than 10,000  
          n=the desired sample size when population is 
more than 10,000  
          N=the estimate of the population size 
            Thus, nf=384/ 1+384]240 
                       =147.6       
                         150 samples    
 
Clinical diagnosis 
This was done at the PMH Antenatal clinic where all 
pregnant women coming for routine checkups 
between the month of November and December in 
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the year 2010 were targeted. The investigator 
explained the intention of the study to the pregnant 
women individually after they were done with the 
checkups before leaving the clinic. Also the 
procedures and the benefits that they could get from 
the study if they agreed to participate. A total of 150 
pregnant women aged between 18-49 years who 
gave written informed consent and signed were 
enrolled in the study. They underwent a face-to-face 
interview using a standardized questionnaire at the 
PMH clinic. Each patient’s history was recorded. 
Demographic and clinical data recorded included 
age, weight, height, occupation, educational level, 
current marital status, smoking status, contraceptive 
use, parity and obstetric history. Data for HIV status 
was obtained from the records in the Antenatal clinic 
with the participants consent. Two vaginal swabs 
were taken from the vaginal wall blindly without the 
use of a speculum so as to target all flora available 
[16] by a Clinical Officer.  
The Amsel clinical diagnosis was done at PMH 
clinic by the investigator involved and required that 
three of the following four criteria be met; first, a 
vaginal pH of greater than pH 4.5; second, the 
presence of clue cells in the vaginal fluid; third, a 
greyish homogenous vaginal discharge; and finally, 
the release of an amine [fishy] odor after addition of 
10%pottassium hydroxide [KOH] to the vaginal 
fluid [8].  The pH was determined with use of the 
first swab which was touched on the pH paper in the 
range covering 4.0 to pH 6.5.The same swab was 
then extracted into 0.2ml of physiological saline in a 
test tube; a drop of the extract was mixed with a drop 
of 10% KOH which was taken on a glass slide. A 
fishy smell indicated a positive test. Two other drops 
from the physiological saline test tube were put on 
separate glass slides, covered with cover slips and 
examined at 400x magnification with a light 
microscope for the presence of clue cells and 
Trichomonas vaginalis. The vaginal epithelial cells 
which were completely covered by the gram variable 
coccobacilli so that their edges which normally have 
a sharply defined cell border became indistinct were 
considered as the clue cells [13]. This preparation 
was also used for detection of Trichomonas 
vaginalis. 
 Laboratory procedures 
For Nugent scoring method, the second swab was 
smeared onto a slide air dried and then transported 
from PMH Antenatal Clinic at room temperatures to 
CMR Microbiology laboratory. The smear was then 
Gram stained by standard methods .The stained slide 
was read and the number of morphotypes evaluated 
based on a standardized scoring method [13]. It was 
then evaluated for the following morphotypes under 
oil immersion [1000x magnification]; large gram 
positive rods [lactobacilli], small gram 
negative/variable rods [G.vaginalis and anaerobic 
rods] and curved Mobiluncus species. A score of 0–3 
was interpreted as consistent with normal vaginal 
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flora; a score of 4–6, corresponding to disturbed 
flora was designated as intermediate; and a score of 
7–10 was considered positive for BV. 
 
Quality Control 
Correct maintenance and set up of the microscopes 
was observed. Preparing and reading of Gram stains 
was observed by every read slide being confirmed by 
two other microscopists. Known positive Gram stain 
smears were always observed before observing 
newly prepared smears. Good practice made sure 
that the report on Gram stained smears mentioned 
the presence or absence of yeast cells. 
 
Statistical analyses 
Both the quantitative and qualitative data were first 
reviewed to identify emerging themes, which were 
then coded for analysis. The qualitative data such 
prevalence of BV and demographic characteristics 
were calculated using chi-square. 
RESULTS 
Demographic characteristics of the study 
population 
The mean age of 150 women enrolled into the study 
was 26.02 years {range 22 [16 – 38 years]; median 
25.5 years; mode of 28 years} with a standard 
deviation of 4.5. Majority [72.7%] of the participants 
were aged 21 - 30 years with the least 4.7% being 
aged 18 to 20 years. 
 
 
 
 
Table1: Education level by age group of the sampled population 
 
Education  
Level 
11 - 20  
Years 
21 - 30  
Years 
31 - 40  
Years Total  df P value 
N % N % N % N % 
None 0 0 2 1.8 0 0 2 1.3 
Primary 3 42.9 46 42.2 18 52.9 67 44.7 3.085 6 0.798 
Secondary 4 57.1 48 44 12 35.3 64 42.7 
Tertiary 0 0 13 11.9 4 11.8 17 11.3 
Total 7 4.7 109 72.7 34 22.7 150 
N - Number; % - Percent;   
Age Group 
-     Chi square; df - Degrees of freedom; P value - Level of significance 
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There were two near equal peaks 42.2% and 44% of those with primary and secondary education being aged 21 to 
30 years. The distribution of education level by age groups was not significantly different (2 = 3.085; df = 6; P 
value= 0.79) as shown in table 1 above. 
 
Table 2: Sexual health characteristics of sampled population 
 
 
Table 2 shows that approximately 16.7% of the 
women were HIV positive as per the Antenatal clinic 
card, with 38% of the women experiencing lower 
abdominal pain. Near half of women 45.3% reported 
experiencing vaginal irritation during the period of 
the study. Approximately one fourth (25.3%) of the 
women reported experiencing vaginal discharge 
during the period of study. Four percent of them 
were reporting previous STI infection (x2=124.97; 
df=1; P value=0.0001) 
 
 
 
Characteristics Frequency Percent  2 df P value 
HIV status 
Positive 25 16.7 66.67 1 0.001 
Negative 125 83.3 
Previous STI infection 
Yes 6 4 124.97 1 0.0001 
No 144 96 
Vaginal irritation 
Yes 68 45.3 1.13 1 0.29 
No 82 54.7 
Vaginal discharge 
Yes 38 25.3 32.83 1 0.001 
No 112 74.7 
Lower abdominal pain 
Yes 57 38 
No 92 61.3 84.28 2 0.0001 
Decline 1 7 
 2 - Chi square; df - Degree of freedom; P - Level of significance; HIV – Human 
immunodeficiency Virus; STI – Sexual Transmitted Diseases 
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Table 3: Sexual behavior genital hygiene of sampled population 
Most of the participants (78%) were currently having 
one sexual partner while about 16% had more than 
one sexual partner. The most (45.3%) commonly 
used contraceptive was the pill with the same 
percentage (45.3%) of the women not using any 
contraceptive. Approximately 24% of the women 
practiced douching with 29.3% of them reporting 
having procured an abortion previously. Nearly half 
(47.3%) of the women reported washing on the 
outside of their genitals immediately after sexual 
encounters. Majority (87.3%) had their sexual 
partners circumcised (x2=215.79; df=2; P 
value=0.001) as shown in table 3 above.
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Figure 1: Occupation characteristics of the respondents 
Figure 1 shows that majority (68%) of the 
participants were unemployed while the rest were 
either business women (18.7%) or 13.4% employed 
(6.7% employed and 6.7% in self-employment) (2 
= 153.68; d6f = 3; P = 0.001).  
Parity of the sampled population 
Fifty six percent of the participants had given birth at 
least once [39.3% one previous births and 17.3% 
more than one previous births] while 43.3% of the 
women were currently expectant. The mean number 
of previous births was 0.79 {range 4 [0 – 4], median 
1 and a standard deviation of 0.87.
 
Figure 2: Marital status of respondents 
Figure 2 shows that more than three quarters of 
women in this study were in a steady relationship 
and only 18.7% were single and had never married. 
The majority (67.3%) of the women were in a 
monogamous marriage with approximately 5.3% 
being in a polygamous marriage (2 = 221.26; df = 
4; P = 0.0001). 
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                               Age at sexual debut of the respondents  
Figure 3: Age at sexual debut of the respondents 
Figure 3 shows that the mean age of sexual debut for 
the women in this study was 17.5 years {range 17 
(19 – 29 years), median 17 years, with a standard 
deviation of 3.3. Majority (74%) of the participants 
had first sex at the age less than 16 years (30% 
between the age of 11 to 15 years and 44% at the age 
of 16 - 20 years) (2 = 71.06; df = 4; P = 0.001).   
Prevalence of bacterial vaginosis among pregnant women attending antenatal clinic at Pumwani Maternity 
Hospital 
The prevalence of BV varied depending on the test 
used although there was no significant different: 
31/150 [20.7%; 95% CI 14.9– 27.9] by Nugent 
criteria and 35/150 [23.3%; 95% CI 17.3 – 30.7] by 
Amsel criteria as shown in Figure 4.
Figure 4: Bacterial Vaginosis Test results for Nugent and Amsel criteria 
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Table 4: Demographic characteristic-specific prevalence of Bacterial Vaginosis infection and bivariate 
prevalence ratios for classical Bacterial Vaginosis infection [versus non-classical Bacterial Vaginosis infection] 
 
 
In multivariate analyses, women who had one 
previous birth were 10% less likely to be infected 
with BV compared to those who were currently 
pregnant and no previous births (PR 0.10, 95% CI 
0.01 to 0.75). Further, women who had given birth to 
more than one child were 9% less likely to have BV 
compared to those who were currently pregnant and 
no previous births (PR 0.09, 95% CI 0.01 to 0.79) as 
indicated in table 4. 
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Table 5: Sexual practices characteristic-specific prevalence of Bacterial Vaginosis infection and bivariate 
prevalence ratios for classical Bacterial Vaginosis infection [versus non-classical Bacterial Vaginosis infection] 
 
 
Table 5 shows that in bivariate analysis, women who 
had T. vaginalis and yeast infections were more 
likely to be infected with BV compared with those 
who had neither T. vaginalis nor yeast infections. 
Also, women who were HIV positive were more 
likely to have BV compared with those who were 
HIV negative (PR 0.57, Cl 0.16 to1.76). In 
multivariate analyses, women who had previous STI 
infection were 58% times more likely to be infected 
with BV compared to women who were not 
previously infected with an STI (PR 3.58, 95% CI 
1.04 to 12.23). 
 
 
 
Characteristics Sample size P value Bivariate P value Multivariate
No % PR (95% CI) PR (95% CI)
T. vaginalis infection
Yes 7 3 42.9 0.197 2.19(0.67 - 7.19) 0.499 NS
No 143 28 19.6 Referent Referent Referent
Yeast infection
Yes 39 7 17.9 0.665 0.83(0.36 - 1.93) 0.232 NS
No 111 24 21.6 Referent Referent Referent
HIV status
Positive 25 3 12 0.304 0.54(0.16 - 1.76) 0.188 NS
Negative 125 28 22.4 Referent Referent Referent
Vaginal Ph
≤ 4.5 84 10 11.9 Referent Referent Referent NS
≥4.5 66 21 31.8 0.011 2.67(1.26 - 5.67) 0.142
Amines (Fishy smell)
Yes 51 19 36.5 0.003 2.98(1.44 - 6.14) 0.119 NS
No 98 12 12.2 Referent Referent Referent
Previous STI infection
Yes 6 3 50 0.12 2.57(0.78 - 8.45) 0.042 3.58(1.04 - 12.23)
No 144 28 19.4 Referent Referent Referent
Vaginal irritation
Yes 68 18 26.5 0.159 0.59(0.29 - 1.22) 0.482 NS
No 82 13 15.6 Referent Referent Referent
Vaginal discharge
Yes 38 14 36.8 0.014 2.43(1.19 - 4.92) 0.514 NS
No 112 17 15.2 Referent Referent Referent
Lower abdominal pain
Yes 57 12 21.1 0.935 1.03(0.5 - 2.12) 0.876 NS
No 93 19 20.4 Referent Referent Referent
BV infection
NS - Not significant; ND - Not done; PR - Prevalence ratio; CI - Confidence interval; No - Number; % - Percentage 
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Table 6: Genital hygiene characteristic-specific prevalence of Bacterial vaginosis infection and bivariate 
prevalence ratios for classical Bacterial vaginosis infection (versus none classical Bacterial vaginosis infection)  
 
In both bivariate and multivariate analyses BV was 
not associated with the age at sexual debut although 
those women who had sex for the first time at the 
age of 16-20 years were more likely to be infected 
with BV. There were no significant relationships 
between BV and douching and also between BV and 
number of sexual partners. In multivariate analysis 
women whose sexual partners were circumcised 
were less likely to be infected with BV compared to 
those whose partners were not circumcised (PR 0.37, 
95% CI 0.15 to 0.92) as shown in table 6. 
Characteristics Sample size P value Bivariate  P value Multivariate 
N %  PR (95% CI) PR (95% CI) 
Age of debut 
11-15 45 10 22.2 0.726 1.25(0.34 - 4.58) 0.99 
16-20 66 12 18.2 0.963 1.03(0.29 - 3.65) 0.99 NS 
21-25 20 6 30 0.453 1.69(0.42 - 6.79) 0.99 
26-30 2 0 0 0.999 ND 0.99 
Declined 17 3 17.7 Referent Referent Referent 
Number of previous sexual partners 
None 9 2 22.2 0.885 0.78(0.32 - 1.93) 0.47 NS 
1 117 23 19.7 0.6 1.13(0.22 - 5.57) 0.825 
> 1 24 6 25 Referent Referent Referent 
Partner circumcised 
Yes 131 24 18.3 0.104 0.49(0.21 - 1.15) 0.033 0.37(0.15 - 0.92) 
No 10 7 36.8 Referent Referent Referent 
Contraceptive use 
None 68 15 22.1 Referent Referent 
Pills 68 13 19.1 1 0.993 
IUCD 3 1 33.3 1 ND 0.993 NS 
Norplant 1 0 0 ND 0.993 
Others 10 2 20 1 0.993 
Practice douching 
Yes 36 8 22.2 0.814 1.11(0.49 - 2.46) 0.879 NS 
No 114 23 20.2 Referent Referent Referent 
Previous abortion 
Yes 44 10 22.7 0.666 0.84(0.39 - 1.81) 0.418 
No 104 20 19.2 Referent Referent Referent NS 
Decline 2 1 50 0.452 2.2(0.28 - 17.180 0.45 
Genital washing after sex 
Yes 69 16 23.2 0.532 1.25(0.62 - 2.53) 0.827 NS 
No 81 15 18.5 Referent Referent Referent 
Number of undergarments 
    ≤ 7 21 3 20.7 Referent Referent Referent NS 
≥  7 129 28 21.7 0.491 1.52(0.46 - 4.99) 0.494 
NS - Not significant; ND - Not done; PR - Prevalence ratio; CI - Confidence interval; N - Number; % - Percentage Referent-
Referred to. 
BV infection 
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DISCUSSION 
Prevalence 
Different studies have identified varying BV 
prevalence in different settings including; 6.4% 
among pregnant women in Burkina Faso [17], 8.6% 
among pregnant women in India [18] and 16% 
among pregnant women in Denmark [19]. In a study 
conducted in Jamaica on the prevalence and risk 
factors of vaginal infections in pregnant women 
44.1% had BV [20]. Also there was a prevalence of 
19.9% among the patients in Belgium [21], 38.8% 
among STD clinic attendees in USA [22], 43% 
among the family planning and STD clinic attendees 
in USA [23] and 44% among female participants 
attending STD clinic in Kenya [24]. 
 Factors associated with Bacterial Vaginosis 
Lack of male circumcision has been associated with 
a number of STIs, including genital ulcer disease 
[25, 26] and acquisition of HIV in men [26]. It is 
therefore biologically plausible that, if BV is 
transmitted by males, the foreskin could facilitate 
survival of BV organisms and render an 
uncircumcised male a more efficient or more 
prolonged transmitter of the infection 
 Women who had previous STI infection other than 
T. vaginalis and HIV were likely to be infected with 
BV compared to women who were not previously 
infected with an STI [PR 3.58, 95% CI= 1.04 to 
12.23]. However, there were no significant 
associations identified between BV and T. vaginalis 
and also BV and HIV status. Paavonen et al., 1983 
[27], found that women with a previous sexually 
transmitted disease are at increased risk of BV. 
Bacterial vaginosis is more prevalent among women 
with a prior or current sexually transmitted disease. 
However, the occurrence of BV may be the direct 
consequence of exposure to the infectious pathogen, 
not the sexual behavior. Although sexually 
transmitted diseases and BV commonly coexist, 
particularly trichomoniasis and BV, BV is not 
considered a sexually transmitted disease [28]. Also 
the association between BV and the risk of HIV 
infections has been demonstrated in several 
longitudinal studies [29], where HIV was more 
frequent in BV positive women than those without 
BV. Moreover, Sub Saharan African women, whose 
vagina microbiota was not dominated by lactobacilli, 
were found to be 2-3times more likely to be infected 
with HIV, even when other HIV risk factors were 
taken into account. It has been suggested that a 
decrease in H2O2-producing lactobacilli in BV might 
contribute to increased rates of HIV infections in 
women with BV. It is widely believed that the acidic 
environment of the vagina in women afforded by 
lactobacilli contributes to the protection against HIV 
infection [29]. There is a growing literature on the 
relationship between BV and an increased risk of 
acquiring HIV-1 infection. Gardnerella vaginalis 
has been shown to activate HIV expression in 
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monocytic and some T cells. The level of expression 
varied with the strain of Gardnerella vaginalis tested 
[30]. In a study by Prosper et al., 2012, the results 
showed no association between BV and HIV 
infection [OR 0.90 [95%CL, 0.28-2.92; p=0.863] 
and this concurred with the findings in this study. 
The findings of these study of being less likely to be 
infected with BV with a past pregnancy contradict a 
previous study by Smart et al., 2004 [31], who found 
that women with BV were more likely to have a past 
pregnancy than controls [P<0.001].  However, 
Prosper et al., 2012 [32], found no evidence of 
association between bacterial vaginosis and having 
ever delivered before [OR 0.66 [95% CL= 0.39-1.12; 
p=0.126]]. 
There was no significant association between BV 
and contraceptive use although the mostly used was 
the pill [n=68] with the same number not having 
used any contraceptive .This association has been 
evident in a number of published studies. Hormonal 
contraceptive, mainly combined methods have been 
reported to be protective against prevalent incident 
[21].While there are a number of confounding 
factors that may explain this association, it is 
consistently evident in the literature, and in many 
analyses. There are also biological plausible 
explanations for this apparent association. A number 
of cross-sectional and longitudinal studies have 
shown a reduced risk of BV in women using 
hormonal contraceptives [21,14]. It has been 
hypothesized that oestrogen increases the glycogen 
content of epithelial cells, a substrate for 
lactobacillus species to generate lactic acid, which 
appears to be a potent inhibitor of BV-associated 
bacteria. It is possible that contraceptive use 
influences the vaginal immune response, with 
Cherpes and co-workers reporting an association 
between hormonal contraceptive use and altered 
vaginal immunity in BV [33]. Smart et al.,2004 [31],  
also concluded that women with BV were 
significantly less likely to have used hormonal 
contraception [OR=0.6, 95%CL; 0.51-0.81]. 
Incidents of BV were not associated with having 
more than one sexual partner. A number of 
investigators have reported an association between 
the development of BV and exposure to a new male 
partner. Smart et al., 2004[31], reported that women 
with two or more male partners in the past 3months 
[OR=1.50, 95%CL; 1.18 to 1.85] and three or more 
in the past 12months [OR=1.60, 95%CL; 1.27 to 
2.02] were significantly more likely to have BV than 
those with fewer partners [14], reported that BV 
recurrence was 3 times more common among 
women who changed sexual partners and was 
significantly less likely among women who 
remained with their regular sexual partner after 
treatment. 
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Despite the fact that several cross-sectional studies 
have shown that frequent douching is associated with 
bacterial vaginosis [34], it remains uncertain whether 
women douche in response to symptoms of bacterial 
vaginosis. Onderdonk et al., 1992 [35], demonstrated 
that use of 0.04% vinegar douche caused a transient 
reduction of total bacterial counts, with most of the 
reduction attributable to the effect of washing the 
vaginal surface as noted with physiologic saline. The 
vaginal flora quickly recovered the levels measured 
before douching. The authors concluded that 
repetitive use of vinegar solution most likely might 
not alter vaginal microflora in a biologically 
important way. In a study by Ness et al.,2002[34], 
women who douched less than once per month had 
no increased risk of bacterial vaginosis [adjusted 
OR=1.0, 95%CL= 0.6-1.7]. Some of the risk factors 
found associated with BV infection which were not 
studied or found associated with BV included lower 
socio economic status, yeast cells, previous abortion, 
education level, age at debut, occupation, and marital 
status, 
CONCLUSIONS, RECOMMENDATIONS AND 
LIMITATIONS 
Conclusions 
The prevalence of this study is much high compared 
to other studies such as 8.6% among pregnant 
women in India and 16% among pregnant women in 
Denmark. 
 
Bacterial vaginosis is associated with factors such as 
male sexual partner not being circumcised, 
primiparous and previous STI’s infection other than 
HIV and T. vaginali. 
Recommendations 
 Routine screening for BV should be carried out 
among pregnant women in order to prevent its 
adverse outcome. Bacterial vaginosis could be 
incorporated into existing STI’s prevention 
programmes. 
 
Multidisciplinary expertise which guarantees 
motivation and enhances information quality about 
STI’s and male circumcision and also treatment of 
STI’s is required. Relationship between BV and 
primiparous needs further exploration. 
 
Limitations 
Limitations included the small number of study 
participants and cross-sectional rather than 
prospective study design 
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